Miraca Life Sciences Announces Significant Plans at the Annual Meeting for ASH
Learn about ICD10 and regulatory compliance by visiting the Miraca booth.
Dallas, Texas (PRWEB) October 29, 2013
Miraca Life Sciences (MLS), the leading pathology services provider that collaborates to make patients and practices better, announced today that it will have a significant presence at the Annual Meeting for the American Society of Hematology (ASH), a conference offering roundtable discussions, hands-on training and health policy updates, on December 7-10 in New Orleans, Louisiana.
Visitors to MLS’ booth can learn important information about forthcoming regulatory guidance and compliance. MLS technical directors will be available to help ASH attendees avoid potential penalties in 2014 and successfully attest to Meaningful Use requirements. MLS technical directors can also help attendees prepare for Meaningful Use audits by ensuring adherence to CMS requirements and prepare for the revolution in medical billing, ICD10.
ASH holds an annual meeting every winter to provide opportunities to grow professionally by learning about the latest clinical updates in research, therapies, and practice strategies through Education and Scientific Programs. In 2013, ASH will showcase the full spectrum of translation in hematology from new basic research to new insights into disease pathogenesis to new therapies for patients to outcome analyses. Networking events allow attendees to connect with more than 20,000 colleagues from around the globe to learn and share ideas.
The 55th Annual Meeting will be held at the Ernest N. Morial Convention Center in New Orleans, Louisiana.
About Miraca Life Sciences
Serving more than 3,500 patients each day, Miraca Life Sciences is a leader in providing an academic-caliber pathology laboratory with diagnostic services in the fields of dermatology, gastroenterology, hematology and urology. Building upon our experience with health IT, we also offer accessible technology solutions to assist healthcare professionals as they work towards accordance with Meaningful Use initiatives.
Miraca Life Sciences, a wholly-owned subsidiary of Japan-based Miraca Holdings Inc., employs a talented team of leading pathologists, histologists, lab technicians, technology consultants, and other medical professionals — all driven to help provide the highest and most up-to-date levels of diagnostic quality, enhanced workflow and practice solutions possible. It is part of our commitment: not only to scientific excellence, but to patients and practices.
The American Society of Hematology (ASH) is the world’s largest professional society concerned with the causes and treatments of blood disorders. The mission of the Society is to further the understanding, diagnosis, treatment, and prevention of disorders affecting the blood, bone marrow, and the immunologic, hemostatic and vascular systems, by promoting research, clinical care, education, training, and advocacy in hematology.
For the original version on PRWeb visit: http://www.prweb.com/releases/2013/10/prweb11278116.htm